(Q58449860)

English

T cell depletion utilizing CD34+ stem cell selection and CD3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients

scientific article published on 08 February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

T cell depletion utilizing CD34(+) stem cell selection and CD3(+) addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Robbie Majzner

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Deirdre Duffy

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Janet Ayello

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Monica Bhatia

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Diane George

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Prakash Satwani

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Lauren Harrison

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Erin Morris

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Mildred Semidei-Pomales

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Joseph Schwartz

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Bachir Alobeid

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Lee Ann Baxter-Lowe

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Angela M Ricci

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Judith S Jacobson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Carmella Van de Ven

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

James H Garvin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Mitchell S Cairo

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

0 references

publication date

8 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

157

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

205-219

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networ

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Haploidentical SCT in children: an update and future perspectives

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Long-term outcome after haploidentical stem cell transplantation in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Haploidentical stem cell transplantation for children with acute leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2012.09048.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58449860&oldid=2089019259"